References
- Adamczyk B, Tharmalingam T, Rudd PM (2011). Glycans as cancer biomarkers. Biochim Biophys Acta, 1820, 1347-53.
- Allen HJ, Ahmed H, Matta KL (1998). Binding of synthetic sulfated ligands by human splenic galectin 1, a betagalactoside-binding lectin. Glycoconj J, 15, 691-5. https://doi.org/10.1023/A:1006988515346
- Baldus SE, Zirbes TK, Hanisch FG, et al (2000) Thomsen-Friedenreich antigen presents as a prognostic factor incolorectal carcinoma: A clinicopathologic study of 264patients. Cancer, 88, 1536-43. https://doi.org/10.1002/(SICI)1097-0142(20000401)88:7<1536::AID-CNCR6>3.0.CO;2-W
- Balog CI, Stavenhagen K, Fung WL, et al (2012). N-glycosylation of colorectal cancer tissues: a liquid chromatographyand mass spectrometry-based investigation. Mol Cell Proteomics, 11, 571-85. https://doi.org/10.1074/mcp.M111.011601
- Chandrasekaran EV, Xue J, Neelamegham S, Matta KL (2006). The pattern of glycosyl- and sulfotransferase activitiesin cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans. Carbohydr Res, 341,983-94. https://doi.org/10.1016/j.carres.2006.02.017
- Essentials of Glycobiology (2009). Cold Spring HarborLaboratory Press, Cold Spring Harbor (NY).
- Feng L, Sun H, Zhang Y, et al (2010). Structural insights into the recognition mechanism between an antitumor galectin AA Land the Thomsen-Friedenreich antigen. FASEB J, 24, 3861-8. https://doi.org/10.1096/fj.10-159111
- Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, Cancer incidence and mortality Worldwide: IARC Cancer Base, No. 11.
- Gunderson LL, Jessup JM, Sargent DJ, et al (2010). Revised TNcategorization for colon cancer based on national survival outcomes data. J Clin Oncol, 28, 264-71. https://doi.org/10.1200/JCO.2009.24.0952
- Huang GL, Guo HQ, Yang F, et al (2012) Activating transcriptionfactor 1 is a prognostic marker of colorectal cancer. Asian Pac J Cancer Prev, 13, 1053-7. https://doi.org/10.7314/APJCP.2012.13.3.1053
- Ideo H, Seko A, Ohkura T, et al (2002). High-affinity binding of recombinant human galectin-4 to SO(3)(-)-->3Galbeta1->3GalNAc pyranoside. Glycobiology, 12, 199-208. https://doi.org/10.1093/glycob/12.3.199
- Ideo H, Seko A, Yamashita K (2005). Galectin-4 binds to sulfatedglycosphingolipids and carcinoembryonic antigen in patcheson the cell surface of human colon adenocarcinoma cells. J Biol Chem, 280, 4730-7. https://doi.org/10.1074/jbc.M410362200
- Indramanee S, Silsirivanit A, Pairojkul C, et al (2012). Aberrant glycosylation in cholangiocarcinoma demonstrated by lectinhistochemistry. Asian Pac J Cancer Prev, 13, 119-24.
- Itzkowitz SH, Yuan M, Montgomery CK, et al (1989). Expressionof Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res, 49, 197-204.
- Liang Y, Feng L, Tong X, et al (2009). Importance of nuclear localization for the apoptosis-induced activity of a fungal galectin AAL (Agrocybe aegerita lectin). Biochem BiophysRes Commun, 386, 437-42. https://doi.org/10.1016/j.bbrc.2009.06.054
- Meany DL, Chan DW (2011). Aberrant glycosylation associatedwith enzymes as cancer biomarkers. Clin Proteomics, 8, 7. https://doi.org/10.1186/1559-0275-8-7
- Qiu Y, Patwa TH, Xu L, et al (2008). Plasma glycoproteinprofiling for colorectal cancer biomarker identificationby lectin glycoarray and lectin blot. J Proteome Res, 7,1693-703. https://doi.org/10.1021/pr700706s
- Rambaruth ND, Greenwell P, Dwek MV (2012). The lectinHelix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer. Glycobiology, 22,839-48. https://doi.org/10.1093/glycob/cws051
- Reis CA, Osorio H, Silva L, et al (2010). Alterations inglycosylation as biomarkers for cancer detection. J Clin Pathol, 63, 322-9. https://doi.org/10.1136/jcp.2009.071035
- Schneider F, Kemmner W, Haensch W, et al (2001). Overexpressionof sialyltransferase CMP-sialic acid:Galbeta1, 3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res, 61, 4605-11.
- Sethi MK, Thaysen-Andersen M, Smith JT, et al (2013). Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and alpha-2,3-linkedsialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines. J Proteome Res, 13, 277-88.
- Storr SJ, Royle L, Chapman CJ, et al (2008). The O-linkedglycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. Glycobiology, 18, 456-62. https://doi.org/10.1093/glycob/cwn022
- Szajda SD, Jankowska A, Zwierz K (2008). Carbohydratemarkers in colon carcinoma. Dis Markers, 25, 233-42. https://doi.org/10.1155/2008/206510
- Yehezkel G, Cohen L, Kliger A, et al (2012). O-linked beta-Nacetylglucosaminylation (O-GlcNAcylation) in primary andmetastatic colorectal cancer clones and effect of N-acetylbeta-D-glucosaminidase silencing on cell phenotype andtranscriptome. J Biol Chem, 287, 28755-69. https://doi.org/10.1074/jbc.M112.345546
- Zhao C, Sun H, Tong X, Qi Y (2003). An antitumour lectinfrom the edible mushroom Agrocybe aegerita. Biochem J,374, 321-7. https://doi.org/10.1042/BJ20030300
Cited by
- Plant Lectins Targeting O-Glycans at the Cell Surface as Tools for Cancer Diagnosis, Prognosis and Therapy vol.18, pp.6, 2017, https://doi.org/10.3390/ijms18061232